Peter Bentham

Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT

Degeneration of basal and limbic networks is a core feature of behavioural variant frontotemporal dementia

The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trial

Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease

Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trial

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial